000 01676 a2200457 4500
005 20250516024058.0
264 0 _c20110929
008 201109s 0 0 eng d
022 _a1592-8721
024 7 _a10.3324/haematol.2010.034389
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCayuela, Jean-Michel
245 0 0 _aCartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost?
_h[electronic resource]
260 _bHaematologica
_cMay 2011
300 _a664-71 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aClinical Laboratory Techniques
_xeconomics
650 0 4 _aCosts and Cost Analysis
650 0 4 _aFusion Proteins, bcr-abl
_xgenetics
650 0 4 _aHumans
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdiagnosis
650 0 4 _aProspective Studies
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aReference Standards
650 0 4 _aReproducibility of Results
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSensitivity and Specificity
700 1 _aMacintyre, Elizabeth
700 1 _aDarlington, Meryl
700 1 _aAbdelali, Raouf Ben
700 1 _aFund, Xavier
700 1 _aVillarese, Patrick
700 1 _aTulliez, Michel
700 1 _aRaffoux, Emmanuel
700 1 _aSigaux, François
700 1 _aRéa, Delphine
700 1 _aSeror, Valerie
773 0 _tHaematologica
_gvol. 96
_gno. 5
_gp. 664-71
856 4 0 _uhttps://doi.org/10.3324/haematol.2010.034389
_zAvailable from publisher's website
999 _c20607046
_d20607046